Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v8-FR
Language French French
Date Updated 2017-10-10 2017-10-10
Drug Identification Number 02357003 02357003
Brand name TEVA-VALSARTAN/HCTZ TEVA-VALSARTAN/HCTZ
Common or Proper name TEVA-VALSARTAN/HCTZ 160/12.5MG TAB PP 30 TEVA-VALSARTAN/HCTZ 160/12.5MG TAB PP 30
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients HYDROCHLOROTHIAZIDE VALSARTAN HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 12.5MG 160MG 12.5MG 160MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-05-20 2017-05-20
Estimated end date 2017-09-20 2017-09-20
Actual end date 2017-09-30 2017-09-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments 50's pack size Available 50's pack size Available
Health Canada comments